Registration number:
Health Innovations (UK) Ltd
for the Year Ended 31 December 2023
Health Innovations (UK) Ltd
(Registration number: 06200615)
Balance Sheet as at 31 December 2023
Note |
2023 |
2022 |
|
Fixed assets |
|||
Tangible assets |
|
|
|
Investments |
|
|
|
|
|
||
Current assets |
|||
Stocks |
|
|
|
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
100 |
100 |
|
Retained earnings |
763,552 |
712,507 |
|
Shareholders' funds |
763,652 |
712,607 |
For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
• |
|
• |
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
Health Innovations (UK) Ltd
(Registration number: 06200615)
Balance Sheet as at 31 December 2023
......................................... |
Health Innovations (UK) Ltd
Notes to the Financial Statements for the Year Ended 31 December 2023
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Plant and machinery |
10% - 33% on cost |
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Staff numbers |
The average number of persons employed by the company (including the director) during the year, was
Health Innovations (UK) Ltd
Notes to the Financial Statements for the Year Ended 31 December 2023
Tangible assets |
Plant and machinery |
Total |
|
Cost or valuation |
||
At 1 January 2023 |
|
|
Additions |
|
|
At 31 December 2023 |
|
|
Depreciation |
||
At 1 January 2023 |
|
|
Charge for the year |
|
|
At 31 December 2023 |
|
|
Carrying amount |
||
At 31 December 2023 |
|
|
At 31 December 2022 |
|
|
Investments |
2023 |
2022 |
|
Investments in subsidiaries |
|
|
Subsidiaries |
£ |
Cost or valuation |
|
At 1 January 2023 |
|
Carrying amount |
|
At 31 December 2023 |
|
At 31 December 2022 |
|
Health Innovations (UK) Ltd
Notes to the Financial Statements for the Year Ended 31 December 2023
Details of undertakings
Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking |
Registered office |
Holding |
Proportion of voting rights and shares held |
|
2023 |
2022 |
|||
Subsidiary undertakings |
||||
|
Unit 26
England and Wales |
|
|
|
|
Hungary |
|
|
|
Debtors |
Current |
Note |
2023 |
2022 |
Trade debtors |
|
|
|
Amounts owed by related parties |
|
|
|
Prepayments |
|
|
|
Other debtors |
|
|
|
|
|
Health Innovations (UK) Ltd
Notes to the Financial Statements for the Year Ended 31 December 2023
Creditors |
Creditors: amounts falling due within one year
2023 |
2022 |
|
Due within one year |
||
Bank borrowings |
8,970 |
- |
Bank overdrafts |
207,337 |
- |
HP and finance lease liabilities |
206,011 |
97,762 |
Trade creditors |
931,419 |
737,771 |
Taxation and social security |
274,107 |
146,767 |
Accruals and deferred income |
6,031 |
11,506 |
Other creditors |
7,470 |
6,359 |
1,641,345 |
1,000,165 |
Creditors: amounts falling due after more than one year
Non-current loans and borrowings
2023 |
2022 |
|
Bank borrowings |
|
|
HP and finance lease liabilities |
|
|
Other borrowings |
|
|
|
|
Related party transactions |
HI kft
There were no disclosable transactions during the year. The balance owing from HI kft at 31 December 2023 was £390,951 (2022 - £390,951).
Vitrition (UK) Ltd
During the year Health Innovations (UK) Ltd made purchases of £Nil (2022 - £58,940) from Vitrition (UK) Ltd. During the year dividend of £Nil (2022 - £550,000) received from Vitrition (UK) Ltd. The balance owing from Vitrition (UK) Ltd at 31 December 2023 was £Nil (2022 - £Nil).